Recherche
-
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19
(European Radiology, 2023-07-05)Article de revueLibre accès -
Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)): Results from a phase 2, randomized, placebo-controlled trial in children and adults
(Clinical Infectious Diseases, 2023-11-15)Article de revueLibre accès -
Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola
(NPJ vaccines. vol. 8, n° 1, pp. 174, 2023-11-08)Article de revueLibre accès -
Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26.ZEBOV/MVA-BN-Filo
(Cell Reports. vol. 42, n° 9, pp. 113101, 2023-09-26)Article de revueLibre accès -
CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada.
(BMJ Open. vol. 13, n° 5, pp. e070837, 2023-05-11)Article de revueLibre accès -
Leveraging Contact Network Information in Clustered Randomized Studies of Contagion Processes.
(Observational Studies. vol. 9, n° 2, pp. 157-175, 2023)Article de revueLibre accès -
More than shots in the dark: driving vaccine efficacy in cirrhosis.
(Gut, 2023-06-07)Article de revue -
Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.
(Journal of Viral Hepatitis. vol. 30, n° 9, pp. 775-786, 2023-06-20)Article de revueLibre accès -
CytOpT: Optimal transport with domain adaptation for interpreting flow cytometry data
(Annals of Applied Statistics. vol. 17, n° 2, pp. 1086-1104, 2023-06-01)Article de revueLibre accès -
Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study
(Epidemics. vol. 46, pp. 100744, 2024-03-01)Article de revueLibre accès